<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED
CONSOLIDATED BALANCE SHEETS, CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS REPORTED IN FORM 10-Q FOR
THE PERIOD ENDED JULY 2, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000925054
<NAME> SPECTRIAN CORP /DE/
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> MAR-31-2001
<PERIOD-START> APR-01-2000
<PERIOD-END> JUL-02-2000
<CASH> 11,179
<SECURITIES> 31,220<F1>
<RECEIVABLES> 27,748
<ALLOWANCES> 420
<INVENTORY> 34,584
<CURRENT-ASSETS> 110,473
<PP&E> 68,380
<DEPRECIATION> 49,400
<TOTAL-ASSETS> 130,721
<CURRENT-LIABILITIES> 33,108
<BONDS> 959
0
0
<COMMON> 12
<OTHER-SE> 96,642
<TOTAL-LIABILITY-AND-EQUITY> 130,721
<SALES> 42,190
<TOTAL-REVENUES> 42,190
<CGS> 35,268
<TOTAL-COSTS> 35,268
<OTHER-EXPENSES> 5,601<F2>
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 46
<INCOME-PRETAX> (3,788)
<INCOME-TAX> 12
<INCOME-CONTINUING> (3,800)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,800)
<EPS-BASIC> (0.35)<F3>
<EPS-DILUTED> (0.35)
<FN>
<F1> Securities, Item 5-02(2), are net of accrued interest and unrealized gain/loss.
<F2> Item consists of research and development.
<F3> Item consists of basic earnings per share.
</FN>
</TABLE>